Amarin Corp Plcuk [AMRN]

Source: 

Company Overview

Amarin Corp Plcuk is a pharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Our commercialized product, VASCEPA was first approved by the United States, or U.S., Food and Drug Administration, or U.S. FDA, for use as an adjunct to diet to reduce triglyceride, or TG, levels in adult patients with severe hypertriglyceridemia, or the MARINE indication, and commercially launched in 2013.